Skip to content

Public FDA record

Z-2220-2011: Eclipse Treatment Planning System, Client software versions 8.0 through 8.6; Model Number: H48; Product

Recall record Z-2220-2011 for Varian Medical Systems, Inc. Oncology Systems. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2220-2011
Company in FDA record
Varian Medical Systems, Inc. Oncology Systems
FDA classification date
May 19, 2011
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

An anomaly in Eclipse Treatment Planning System, versions 8.0 to 8.6, whereby Actual SSD (source surface distance) value may not correspond to the Planned SSD value after Planning Approval.

Source facts

Action
The firm, Varian Medical, sent an "URGENT MEDICAL DEVICE CORRECTION" letter dated April 4, 2011, to its customers. ***12-20-12, AMENDED INFO ***: An additional letter was sent to consignees on 11/5/12 that Varian identified as also being affected by the recall.*** The letter describes the product, problem and actions to be taken. The customers were instructed to do the following: 1) Set the Planning Approved status in Eclipse (Eclipse displays both the Actual and Planned SSD values during plan approval) and verify both SSD values prior to approving the plan. 2)Verify the SSD values in the Eclipse Treatment Plan Report prior to approving the plan for treatment or proceeding with treatment delivery (this report lists both the Actual and Planned SSD values). 3) Prior to approving the plan in RT Chart, verify both the Actual and Planned SSD values in the Parameters Workspace by selecting Field Parameters>Geometry tab. 4) Prior to treatment, they should verify intended SSD values during independent MU calculation. 5)Re-familiarize themselves with the concepts of Actual SSD and Planned SSD by reviewing the listed information. Please advise the appropriate personnel working in your radiotherapy department of the content of this letter. Varian mitigated the product behavior in version 8.9. If you require further clarification, please feel free to contact the Varian Oncology Help Desk ; phone: USA and Canada - 1888-827-4265; Europe: +41 41 749 8844; email: North America: support-americas@varian.com; Australia/New Zealand: support-anz@varian.com; Europe: support-emea@varian.com; South East Asia: seasia.apps.helpdesk@varian.com; China/Asia: china.apps.helpdesk@varian.com; Japan: Japan.Apps.Helpdesk@varian.com; Latin America: soporte.al@varian.com; Internet: Oncology Systems-www.myvarian.com; Varian Medical Systems -www.varian.com; or your local Varian Customer Support District or Regional Manager.
Initiated
2011-04-04
Root cause
Software design
Terminated
2012-06-27
Distribution
Worldwide distribution.
Recall number
Z-2220-2011
Recall status
Terminated
CDRH record ID
99625
FDA classified
2011-05-19
Recall event number
58581

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗